Renaissance Capital logo

Regulus Therapeutics Priced, Nasdaq: RGLS

Early stage biotech developing microRNAs treatments for multiple serious diseases.

Industry: Health Care

First Day Return: +5.0%

Early stage biotech developing microRNAs treatments for multiple serious diseases.
IPO Data
IPO Date 10/04/2012
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $45
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters San Diego, CA, United States
Founded 2007
Employees at IPO 56
Website www.regulusrx.com

Regulus Therapeutics (RGLS) Performance

Created with Highcharts 10.3.2Chart context menuRGLS vs. IPO Index (IPOUSA)20132014201520162017201820192020202120222023202420250%+ 500%-250%+ 250%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index